Provided by Tiger Fintech (Singapore) Pte. Ltd.

DiaMedica Therapeutics Inc.

7.16
+1.0216.61%
Pre-market: 7.330.1700+2.37%04:28 EDT
Volume:2.13M
Turnover:14.92M
Market Cap:370.09M
PE:-10.37
High:7.49
Open:6.98
Low:6.57
Close:6.14
52wk High:7.49
52wk Low:3.19
Shares:51.69M
Float Shares:32.94M
Volume Ratio:4.94
T/O Rate:6.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6903
EPS(LYR):-0.6050
ROE:-73.41%
ROA:-44.55%
PB:13.62
PE(LYR):-11.84

Loading ...

Richard Jacinto II Reports Acquisition of Common Shares in DiaMedica Therapeutics Inc

Reuters
·
Jul 26

DiaMedica Therapeutics Closes $30.1 Million Private Placement to Advance Clinical-Stage Biopharmaceutical Initiatives

Reuters
·
Jul 24

DiaMedica Therapeutics Announces Closing of $30.1 Million Private Placement

THOMSON REUTERS
·
Jul 24

DiaMedica Therapeutics to Raise $30 Million Via Private Placement

MT Newswires Live
·
Jul 21

Diamedica Therapeutics Is Maintained at Buy by Lake Street

Dow Jones
·
Jul 18

DiaMedica Therapeutics Announces Promising Interim Phase 2 Results for Preeclampsia Treatment with DM199, Showing Significant Blood Pressure Reduction and No Placental Transfer

Reuters
·
Jul 17

DiaMedica Therapeutics Joins Russell 2000 and 3000 Indexes

Reuters
·
Jun 24

Diamedica Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
May 29

BRIEF-DiaMedica Therapeutics Announces Poster Presentation At European Stroke Organisation Conference – ESOC 2025

Reuters
·
May 15

DiaMedica Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

BRIEF-DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights

Reuters
·
May 14

DiaMedica Therapeutics Reports Increased Net Loss of $7.7 Million and Loss Per Share of $0.18 in Q1 2025

Reuters
·
May 14

DiaMedica Therapeutics Inc expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
May 10

DiaMedica Therapeutics Inc expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
May 02

DiaMedica Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 18

Press Release: DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results

Dow Jones
·
Mar 18

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 17